Prof. Tony Mok (2nd left), Chairman of the Department of Clinical Oncology and Li Shu Fan Medical Foundation Professor of Clinical Oncology, received the award for his contribution to and leadership in lung cancer research worldwide. Considered as ‘a legend in medical oncology’ and ‘the first one to put personalized medicine in advanced lung cancer’, Professor Mok’s main research interest focuses on biomarker and molecular targeted therapy in lung cancer. Much of his research has shifted the treatment paradigm and defined the current management of lung cancer.
This article was originally published in No. 527, Newsletter in Nov 2018.